Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of mometasone/formoterol inhalation aerosol in adults with chronic persistent asthma
CTR20200010Phase 3Active
- Sponsor
- Omni Pharmaceutical
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone, formoterol in asthma, sponsored by Omni Pharmaceutical. Started Jan 2021; status: active.
02
Drugs
mometasoneformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20200010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200010.